Suchergebnisse - "Trachtman, Howard"

PubPharm (25)

1

Sparsentan versus Irbesartan in Focal Segmental Glomerulosclerosis

enthalten in: The New England journal of medicine | 2023

von Rheault, M. | Alpers, C. | Barratt, J. | +125

CommentIn: N Engl J Med. 2024 Mar 21;390(12):1153-1154. - PMID 38507767

2

Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT) : 2-year results from a randomised, active-controlled, phase 3 trial

enthalten in: Lancet (London, England) | 2023

von Rovin, B. | Barratt, J. | Heerspink, H. | +130

CommentIn: Lancet. 2023 Dec 2;402(10417):2046-2047. - PMID 37931627

3

Sparsentan in patients with IgA nephropathy : a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial

enthalten in: Lancet (London, England) | 2023

von Heerspink, H. | Radhakrishnan, J. | Alpers, C. | +115

CommentIn: Lancet. 2023 May 13;401(10388):1548-1550. - PMID 37015245

4

Comparing Kidney Health Outcomes in Children, Adolescents, and Adults With Focal Segmental Glomerulosclerosis

enthalten in: JAMA network open | 2022

von Gipson, D. | Troost, J. | Spino, C. | +33

5

Clinical Outcomes of Patients with C3G or IC-MPGN Treated with the Factor D Inhibitor Danicopan : Final Results from Two Phase 2 Studies

enthalten in: American journal of nephrology | 2022

von Nester, C. | Appel, G. | Bomback, A. | +18

ErratumIn: Am J Nephrol. 2023 Jan 19;:1. - PMID 36657419

6

Proteinuria Reduction and Kidney Survival in Focal Segmental Glomerulosclerosis

enthalten in: American journal of kidney diseases : the official journal of the National Kidney Foundation | 2021

von Troost, J. | Trachtman, H. | Spino, C. | +9

7

DUET : A Phase 2 Study Evaluating the Efficacy and Safety of Sparsentan in Patients with FSGS

enthalten in: Journal of the American Society of Nephrology : JASN | 2018

von Trachtman, H. | Nelson, P. | Adler, S. | +58

ErratumIn: J Am Soc Nephrol. 2019 Mar;30(3):518. - PMID 36632636

8

A possible influence of age on absorption and elimination of adalimumab in focal segmental glomerulosclerosis (FSGS)

enthalten in: European journal of clinical pharmacology | 2016

von Ternant, D. | Paintaud, G. | Trachtman, H. | +2

9

Adiponectin in children and young adults with focal segmental glomerulosclerosis

enthalten in: Pediatric nephrology (Berlin, Germany) | 2015

von Sethna, C. | Boone, V. | Kwok, J. | +2

10

Efficacy of galactose and adalimumab in patients with resistant focal segmental glomerulosclerosis : report of the font clinical trial group

enthalten in: BMC nephrology | 2015

von Trachtman, H. | Vento, S. | Herreshoff, E. | +10